Abstract
Critical limb ischemia (CLI) is treated with surgical or endovascular technique to restore blood flow as distally as possible. Neuromodulation in the form of spinal cord stimulation (SCS) is offered to patients who have severe debilitating chronic pain and who are not amenable to conventional drug therapy or surgical bypass. SCS delivers small electrical fields to the spinal cord, which mask areas of pain by changing the pain messages to the brain. Additionally, the ischemic pain is thought to be relieved due to complementary mechanisms of antidromic vasodilation and decreased sympathetic efferent activity. For SCS implantation, patients should be 18 years of age or older, be willing to stop or reduce excessive medication, and be able to manage the technical demands of the equipment. The primary purpose of SCS is to improve QOL by reducing the severity of pain. Obvious contraindications are anatomical problems when it is not possible to implant a spinal cord stimulation system safely, active infective illness or local site infection, or psychiatric illnesses/untreated drug addiction/metal allergy. Common complications of SCS include painful battery/connection site, infection (less than 5 %), and unpleasant stimulation/decrease in pain relief with time. This brief review suggests that SCS results in pain relief, improved quality of life (QOL), healing of ulcers, and reduced amputation rates; however, more objective studies focused on assessment of microcirculatory blood flow of skin; before and after SCS are needed to quantify its efficacy in improving circulation. SCS should be offered in an environment of multidisciplinary pain management, in parallel with other therapies and should be used as part of an overall rehabilitation strategy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965;150:971–9.
Shealy CN, Mortimer JT, Reswick JB. Electrical inhibition of pain by stimulation of the dorsal columns: preliminary clinical report. Anesth Analg. Jul–Aug 1967;46(4):489–91
Cook AW, Oygar A, Baggenstos P, Pacheco S, Kleriga E. Vascular disease of extremities: electrical stimulation of spinal cord and posterior roots. N Y State J Med. 1976;76:366–8.
Linderoth B, Foreman RD. Mechanisms of spinal cord stimulation in painful syndromes: role of animal models. Pain Med. 2006;7 Suppl 1:s14–26.
Wu M, Komori N, Qin C, Farber JP, Linderoth B, Foreman RD. Extracellular signal-regulated kinase (ERK) and protein kinase B (AKT) pathways involved in spinal cord stimulation (SCS)- induced vasodilation. Brain Res. 2008;1207:73–83.
Tanaka S, Komori N, Barron KW, Chandler MJ, Linderoth B, Foreman RD. Mechanisms of sustained cutaneous vasodilation induced by spinal cord stimulation. Auton Neurosci. 2004;114:55–60.
Wu M, Thorkilsen M, Qin C, Farber JP, Linderoth B, Foreman RD. Effects of spinal cord stimulation on peripheral circulation in stretozotocin-induced diabetic rats. Neuromodulation. 2007;10:217–23.
Wu M, Komori N, Qin C, Farber JP, Linderoth B, Foreman RD. Roles of peripheral terminals of transient receptor potential vanilloid-1 containing sensory fibers in spinal cord stimulation induced peripheral vasodilation. Brain Res. 2007;1156:80–92.
Transatlantic Inter-Society Consensus (TASC). Section D: chronic critical limb ischaemia. Management of peripheral arterial disease. Eur J Vasc Endovasc Surg. 2000;19 Suppl A:S144–243.
Augustinson LE, Carlson CA, Holm J, Jivergard L. Epidural electric stimulation in severe limb ischemia. Pain relief, increased blood flow and possible limb-saving effect. Ann Surg. 1985;202:104–10.
Pluijms W, Huygen F, Cheng J, Mekhail N, van Kleef M, Van Zundert J, et al. Evidence-based interventional pain medicine according to clinical diagnoses. 18. Painful diabetic polyneuropathy. Pain Pract. 2011;11:191–8.
Ubbink DT, Vermeulen H. Spinal cord stimulation for critical leg ischemia: a review of effectiveness and optimal patient selection. J Pain Symptom Manage. 2006;31 Suppl 4:S30–5.
Ubbink DT, Vermeulen H. Spinal cord stimulation for non-reconstructable chronic critical leg ischaemia. Cochrane Database Syst Rev. 2005;3:CD004001.
Claeys LG, Horsch S. Transcutaneous oxygen pressure as predictive parameter for ulcer healing in end-stage vascular patients treated with spinal cord stimulation. Int Angiol. 1996;15:344–9.
Gersbach P, Hasdemir MG, Stevens RD, Nachbur B, Mahler F. Discriminative microcirculatory screening of patients with refractory limb ischaemia for dorsal column stimulation. Eur J Vasc Endovasc Surg. 1997;13:464–71.
Gersbach PA, Argitis V, Gardaz JP, von Segesser LK, Haesler E. Late outcome of spinal cord stimulation for unreconstructable and limb-threatening lower limb ischemia. Eur J Vasc Endovasc Surg. 2007;33(6):717–24.
Galley D, Rettori R, Boccalon H, Medvedowsky A, Lefebvre JM, Sellier F, et al. La stimulation électrique médullaire dans les arteriopathies des membres inférieurs. Une étude multicentrique chez 244 patients. J Mal Vasc. 1992;17:208–13.
Amann W, Berg P, Gersbach P, Gamain J, Raphael JH, Ubbink DT. Spinal cord stimulation in the treatment of non-reconstructable stable critical leg ischaemia: results of the European Peripheral Vascular Disease Outcome Study (SCS-EPOS). Eur J Vasc Endovasc Surg. 2003;26:280–6.
Jivegard LE, Augustinsson LE, Holm J, Risberg B, Ortenwall P. Effects of spinal cord stimulation (SCS) in patients with inoperable severe lower limb ischaemia: a prospective randomized controlled study. Eur J Vasc Endovasc Surg. 1995;9:421–5.
Jivegard LE, Augustinsson LA, Carlsson CA, Holm J. Long-term results by epidural spinal electrical stimulation (ESES in patients with inoperable severe lower limb ischaemia. Eur J Vasc Surg. 1987;1:345–9.
Klomp HM, Spincemaille GH, Steyerberg EW, Habbema JD, van Urk H. Spinal-cord stimulation in critical limb ischaemia: a randomized trial. ESES study group. Lancet. 1999 Mar 27;353:1040–4.
Klomp HM, Steyerberg EW, Habbema JD, van Urk H, ESES study group. What is the evidence on efficacy of spinal cord stimulation in (subgroups of) patients with critical limb ischemia? Ann Vasc Surg. 2009;23:355–63. Epub 2009 Jan 6. Review.
Klomp HM, Steyerberg EW, van Urk H, Habbema JD, ESES Study Group. Spinal cord stimulation is not cost-effective for non-surgical management of critical limb ischaemia. Eur J Vasc Endovasc Surg. 2006;31:500–8.
Truin M, van Kleef M, Linderoth B, Smits H, Janssen SP, Joosten EA. Increased efficacy of early spinal cord stimulation in an animal model of neuropathic pain. Eur J Pain. 2011;15:111–7.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Agarwal, P., Sharma, D. (2017). Spinal Cord Stimulation. In: Dieter, R., Dieter, Jr, R., Dieter, III, R., Nanjundappa, A. (eds) Critical Limb Ischemia. Springer, Cham. https://doi.org/10.1007/978-3-319-31991-9_41
Download citation
DOI: https://doi.org/10.1007/978-3-319-31991-9_41
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-31989-6
Online ISBN: 978-3-319-31991-9
eBook Packages: MedicineMedicine (R0)